Many epileptic patients are not cured for a long time, and even become more and more serious, which is certainly related to the complexity of the condition itself, and there are often cases where unclear diagnosis leads to improper or even wrong choice of treatment methods. It is common for neurologists in some primary care hospitals to mistakenly diagnose cases with only convulsions such as low calcium convulsions, hypoglycemia, and pediatric hyperthermia as epilepsy, and to inappropriately administer antiepileptic drugs for a long time. In fact, there are several subdivisions of epilepsy. In fact, there are dozens of types of epilepsy, and each type has its own applicable drugs or surgical methods, so taking anti-epileptic drugs at will, regardless of their redness, is difficult to achieve satisfactory results and can even lead to aggravation of epilepsy. For example, carbamazepine is an internationally recognized classical antiepileptic drug, but if not used appropriately in some adolescent patients with myoclonic or atonic seizures, it can lead to increased seizures and aggravation. In female patients of childbearing age with significant depression, the new antiepileptic drug lamotrigine (Librium) can be used to effectively relieve depression while controlling seizures, and does not affect the patient’s reproductive function. Therefore, before formal treatment begins, epilepsy patients must undergo scientific examination in order to discern the specific typing and severity of epilepsy and to treat the symptoms with the best possible outcome.